Design and Synthesis of 2-substituted [1,2,4]Triazolo[1,5-a]pyrimidines Tethered with Umbelliferone as Selective Carbonic Anhydrase IX and XII Inhibitors
In this study, we have identified compound 3d as a selective inhibitor of the isoforms hCA IX and XII, showing minimal inhibition over hCA I, II, and IV isoenzymes (selectivity indices > 100). Its moderate inhibitory effects on hCA IX and XII at submicromolar levels were paralleled by significant antiproliferative activity against HD-MB03 cells. These findings underscore the potential of compound 3d as a promising candidate for further therapeutic development, especially in combination with clinically used chemotherapeutic agents.
Authors
- Roberta Bortolozzi (ORCID: https://orcid.org/0000-0002-3357-4815)
- Alessio Nocentini (ORCID: https://orcid.org/0000-0003-3342-702X)
- Lorenzo Manfreda (ORCID: https://orcid.org/0000-0002-4590-0139)
- Claudiu T. Supuran (ORCID: https://orcid.org/0000-0003-4262-0323)
- Romeo Romagnoli
- Giampietro Viola (ORCID: https://orcid.org/0000-0001-9329-165X)
- Andrea Brancale (ORCID: https://orcid.org/0000-0002-9728-3419)
- Elena Romagnoli
- Arianna Zanolli
Institutions
- Marche Polytechnic University (IT)
- University of Padua (IT)
- University of Ferrara (IT)
- Città della Speranza Foundation (IT)
- University of Florence (IT)
- University of Chemistry and Technology, Prague (CZ)
Publication Details
- Journal
- Anti-Cancer Agents in Medicinal Chemistry
- Published
- 2025-03-28
- DOI
- https://doi.org/10.2174/0118715206373602250318062414
- Primary Topic
- Enzyme function and inhibition
- Type
- article
- Field-Weighted Citation Impact
- 0.00